Imaging Biometrics Ltd (IBAI)

Currency in GBP
0.65
0.00(0.00%)
Closed·
IBAI Scorecard
Full Analysis
Stock has taken a big hit over the last week
IBAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.600.70
52 wk Range
0.012.10
Key Statistics
Bid/Ask
0.50 / 0.70
Prev. Close
0.65
Open
0.7
Day's Range
0.6-0.7
52 wk Range
0.01-2.1
Volume
434.18K
Average Volume (3m)
503.06K
1-Year Change
-50%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IBAI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Imaging Biometrics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Imaging Biometrics Ltd Company Profile

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routine MR exams; IB DCE and IB Diffusion that provide whole body insights on blood flow and water diffusion; StoneChecker and Liver Surface Nodularity, which are computed tomography processing applications designed to assist clinicians in the non-invasive assessment of kidney stones and liver health; IB ASL to measure cerebral blood flow to assess stroke, dementia, and other neurological conditions; IB Zero G, a technology designed to eliminate the need for gadolinium contrast agents in standard imaging; and IB Nimble, which supports healthcare providers through virtual collaboration among clinicians. It is also involved in the development of IB003, a gallium maltolate drug candidate in Phase 1 clinical trial for the treatment of glioblastoma. In addition, the company offers consulting services. The company was formerly known as IQ-AI Limited and changed its name to Imaging Biometrics Ltd. in May 2025. Imaging Biometrics Ltd. was incorporated in 1965 and is based in Saint Helier, Jersey.

Compare IBAI to Peers and Sector

Metrics to compare
IBAI
Peers
Sector
Relationship
P/E Ratio
−4.8x−2.7x−0.5x
PEG Ratio
−0.090.030.00
Price/Book
5.2x0.5x2.6x
Price / LTM Sales
2.1x1.4x3.2x
Upside (Analyst Target)
-84.6%42.7%
Fair Value Upside
Unlock22.4%5.8%Unlock

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
305.86K / --
EPS Revisions
Last 90 days

IBAI Income Statement

FAQ

What Stock Exchange Does Imaging Biometrics Trade On?

Imaging Biometrics is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Imaging Biometrics?

The stock symbol for Imaging Biometrics is "IBAI."

What Is the Imaging Biometrics Market Cap?

As of today, Imaging Biometrics market cap is 1.58M.

What Is Imaging Biometrics's Earnings Per Share (TTM)?

The Imaging Biometrics EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is IBAI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Imaging Biometrics Stock Split?

Imaging Biometrics has split 0 times.

How Many Employees Does Imaging Biometrics Have?

Imaging Biometrics has 7 employees.

What is the current trading status of Imaging Biometrics (IBAI)?

As of 23 Jul 2025, Imaging Biometrics (IBAI) is trading at a price of 0.65, with a previous close of 0.65. The stock has fluctuated within a day range of 0.60 to 0.70, while its 52-week range spans from 0.01 to 2.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.